Physician profile
Christopher Lai
NPI 1508905159
$34,057.55
in general payments reported to CMS, 2019-2025
19 companies · $1,225 in 2025
The $1,225 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,620 · 2020: $11K · 2021: $9,099 · 2022: $515 · 2023: $2,121 · 2024: $2,319 · 2025: $1,225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,099 · Travel and Lodging: $2,566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,098.62 |
| Travel and Lodging | $2,566.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Orthopaedic Solutions, INC. | $11,100.00 | 2019-2020 | |
| Stryker Corporation | $9,080.78 | 2019-2025 | Mako, Insignia |
| Arthrex, INC. | $8,300.00 | 2021 | |
| Smith+Nephew, INC. | $2,505.39 | 2019-2024 | Journey II, Legion Revision, Or3o Dual Mobility |
| Encore Medical, LP | $1,612.84 | 2020-2024 | Djo Surgical |
| Zimmer Biomet Holdings, INC. | $485.94 | 2021-2025 | Persona, Tapestry, Accufill |
| Trice Medical, INC. | $200.00 | 2019 | |
| Conformis, INC. | $191.30 | 2022 | |
| Insight Medical Systems, INC. | $123.66 | 2023 | Arvis |
| Linvatec Corporation | $119.67 | 2019 | |
| US Implant Solutions, LLC | $81.88 | 2023 | |
| Pacira Therapeutics, INC. | $66.63 | 2019 | |
| Ermi LLC | $52.84 | 2019-2020 | |
| Next Science LLC | $31.43 | 2021 | |
| Carbofix Orthopedics INC | $29.03 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $26.24 | 2019 | |
| Depuy Synthes Sales INC. | $20.69 | 2019 | |
| Amgen INC. | $15.20 | 2025 | Prolia, Evenity |
| Bioventus LLC | $14.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Lai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.